| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $281.9M | +6.7% | +19.8% |
| Cost of Revenue | $94.9M | +9.6% | +21.7% |
| Gross Profit | $187.0M | +5.2% | +18.9% |
| R&D Expense | $51.2M | +6.4% | +30.5% |
| SG&A Expense | $39.1M | -0.2% | +45.1% |
| Operating Income | -$41.6M | -2.0% | -69.9% |
| Pre-tax Income | -$40.8M | +2.5% | +42.8% |
| Income Tax | -$4.8M | +84.6% | +59.5% |
| Net Income | -$36.0M | -240.9% | +39.5% |
| EPS (Basic) | -$0.06 | -200.0% | +97.8% |
| EPS (Diluted) | -$0.06 | -200.0% | +97.8% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $298.1M | +10.0% | +337.3% |
| Accounts Receivable | $215.6M | +6.0% | — |
| Current Assets | $669.5M | +6.8% | — |
| Total Assets | $7.47B | +0.4% | — |
| Current Liabilities | $525.1M | +4.1% | — |
| Long-term Debt | $0 | — |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $6.7M | — | — |
| Capital Expenditures | $4.2M | — | — |
| Investing Cash Flow | -$28.7M | — | — |
| Financing Cash Flow | $202.0M | — | — |
| Free Cash Flow | $2.5M | — | — |
| — |
| Total Liabilities | $645.2M | +2.4% | — |
| Stockholders' Equity | $6.83B | +0.2% | +1005.6% |